loader2
Partner With Us NRI

Concord Drugs Ltd share Price Today

Company details

36.05
37.74
25.56
61.50
6M Return 5.57%
1Y Return 24.84%
Mkt Cap.(Cr) 36.94
Volume 5,473
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 5,473

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Concord Drugs Ltd shares SWOT Analysis

Strengths (4)

  • Company with Low Debt
  • Book Value per share Improving for last 2 years
  • Company with Zero Promoter Pledge

Weakness (8)

  • Inefficient use of shareholder funds - ROE declining in the last 2 years
  • Inefficient use of assets to generate profits - ROA declining in the last 2 years
  • Degrowth in Revenue and Profit

Opportunity (0)

Data not found

Threats (2)

  • Companies with growing costs YoY for long term projects
  • High PE (PE > 40)

Resistance and support

R1 37.8
R2 38.6
R3 39.5
Pivot

36.91

S1 36.1
S2 35.2
S3 34.4
EMA SMA
37.1
38.4
38.9
37.5
36.6
38.8
41.2
37.2
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
LAKSHMI PRASANNA PALLETI Bulk Sell 2024-01-15 44.63 51994 BSE
MATALIA STOCK BROKING PRIVATE LIMITED Bulk Purchase 2023-12-29 58.36 59398 BSE
MATALIA STOCK BROKING PRIVATE LIMITED Bulk Sell 2023-12-29 57.71 59398 BSE
Name Category Shares
NAGI REDDY SEELAM PROMOTER 29.13%
MANOJ KUMAR REDDY SEELAM PROMOTER 16.28%
SEELAM KONI REDDY PROMOTER 10%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Concord Drugs Ltd Stocks COMPARISON

Financials( in Cr) Concord Drugs Ltd Sun Pharmaceuticals Industries Ltd Cipla Ltd Dr Reddys Laboratories Ltd Divis Laboratories Ltd
Price 36.94 1,540.10 1,354.85 6,016.10 3,737.50
% Change 1.18 1.14 0.68 1.23 1.79
Mcap Cr 36.94 369,521.58 109,383.81 100,353.96 99,219.04
Revenue TTM Cr 52.08 43,885.68 15,790.60 24,669.70 7,767.51
Net Profit TTM Cr 0.99 8,560.84 2,513.47 4,507.30 1,823.38
PE TTM 38.08 39.38 27.65 19.19 71.71
1 Year Return 24.84 54.71 48.57 22.54 11.81
ROCE 6.04 16.79 14.76 25.99 19.30
ROE 3.30 16.46 10.66 21.21 14.89
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 31.14 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 19,463.02 -3,609.06
LAST 3M 83,632.14 32,580.07
LAST 6M 140,794.69 70,960.51
LAST 12M 216,582.31 196,780.81

Concord Drugs Ltd Information

Stock PE (TTM)
38.08
Promoter Holding
55.41%
Book Value
35.3996
ROCE
6.04%
ROE
3.3%
Description
  • CONCORD DRUGS LIMITED is a public limited company established in 1995, is among the respected pharmaceutical companies in India for manufacturing of Finished Pharmaceutical Formulations like Injectables (Small volume parenterals, Dry powder ) ,Tissue Bio-Adhesive, tablets, capsules and ophthalmic preparations and Ready-to-fill Pellets. State of the art technology having dedicated manufacturing facilities for Liquid Injections, Dry powder Injections and Ready-to-fill Pellets ensures the highest level of process integrity and product quality. The company started with Finished Pharmaceutical Formulations and then diversified into Ready-to-fill Pellets, to provide our customers with end-to-end solution to their various pharmaceutical product needs to commercial contract drug manufacturing. The company operates a state of the art, cGMP contract manufacturing Formulation-Fill-Finish facility, providing comprehensive pharmaceutical development and manufacturing services for drug products. The company has two manufacturing facilities built to comply with standards stipulated by Regulatory bodies.

Registered Address

Survey No 249 Brahmanapally V, Hayathnagar M, Ranga Reddy, Telangana, 501511

Tel : 91-40-24036379
Email : concorddrugsltd:gmail.com
Website : http://www.concorddrugs.in
Registrar

Aarthi Consultants Pvt Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 538965
NSE Code :
Book Closure Date (Month) : Sep
BSE Group : XT
ISIN : INE858L01010

FAQ’s on Concord Drugs Ltd Shares

You can buy Concord Drugs Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Concord Drugs Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Apr 22, 2024 04:01 PM the closing price of Concord Drugs Ltd was ₹ 36.94.

Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Apr 22, 2024 04:01 PM, the market cap of Concord Drugs Ltd stood at ₹ 36.94.

The latest PE ratio of Concord Drugs Ltd as of Apr 22, 2024 04:01 PM is 38.08

The latest PB ratio of Concord Drugs Ltd as of Apr 22, 2024 04:01 PM is 0.96

The 52-week high of Concord Drugs Ltd share price is ₹ 61.50 while the 52-week low is ₹ 25.56

Download Our

Download App
market app